Not recruiting
Ovarian cancer+1
Not recruitingStudy Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer
Registered drugNo placebo
Study Comparing Niraparib and Platinum-Taxane Drug Combination for Patients with Advanced Ovarian Cancer
Registered drugNo placebo
- Disease:Ovarian cancerHomologous recombination deficiency positive advanced ovarian cancer
- Substances:BevacizumabCarboplatin+2
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Bevacizumab
- Sponsor:Tesaro Inc.
